Nelson Robert G, Pavkov Meda E, Hanson Robert L, Knowler William C
Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85014-4972, USA.
Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1(Suppl 1):S10-4. doi: 10.1016/j.diabres.2008.09.014. Epub 2008 Oct 7.
Pima Indians from the Gila River Indian Community in Arizona have a high incidence rate of type 2 diabetes, and kidney disease attributable to diabetes is a major cause of morbidity and mortality in this population. Since 1965, each member of the population at least 5 years of age is invited to participate in a research examination every other year. During the past 43 years, the overall incidence of diabetes in the Pima Indians has not changed, but the incidence of diabetes among those less than 15 years of age has increased nearly 6-fold, as an increasing prevalence and degree of obesity in the youth have shifted the onset of diabetes to younger ages. The rising frequency of diabetes in the youth has led, in turn, to the emergence in mid-life of the major complications of diabetes, including kidney disease. On the other hand, the introduction and widespread use of medicines to control blood pressure, reduce hyperglycemia, and block the renin-angiotensin system (RAS) have lead to improvements in the average blood pressure and glycosylated hemoglobin levels in the diabetic population. These countervailing forces have influenced the course of diabetic nephropathy in a generally favorable direction in the past few years, as evidenced by the decline in the overall incidence of end-stage kidney disease since 1990. A continued increase in the incidence of type 2 diabetes in youth, however, threatens to reverse this trend.
来自亚利桑那州吉拉河印第安社区的皮马印第安人2型糖尿病发病率很高,糖尿病所致的肾脏疾病是该人群发病和死亡的主要原因。自1965年以来,该人群中年龄至少5岁的成员每隔一年被邀请参加一次研究检查。在过去的43年里,皮马印第安人糖尿病的总体发病率没有变化,但15岁以下人群的糖尿病发病率增加了近6倍,因为青少年肥胖患病率和肥胖程度的增加已将糖尿病发病年龄提前。青少年糖尿病发病率的上升反过来又导致糖尿病的主要并发症在中年出现,包括肾脏疾病。另一方面,控制血压、降低高血糖和阻断肾素-血管紧张素系统(RAS)的药物的引入和广泛使用,使糖尿病患者的平均血压和糖化血红蛋白水平有所改善。在过去几年里,这些相反的力量总体上朝着有利于糖尿病肾病进程的方向发挥了作用,自1990年以来终末期肾病的总体发病率下降就证明了这一点。然而,青少年2型糖尿病发病率的持续上升可能会扭转这一趋势。